MAAD Scientist Technologies

Nano‑Bonded Solutions for Everyday Comfort:



MAAD Platforms

MAAD-based molecular diagnostics for research, clinical, and point-of-care use


MAAD Diagnostics Platforms:

Modular molecular tools for research, clinical, and point-of-care detection. MAAD’s diagnostics portfolio uses Molecular Anchoring & Adaptive Design to replace costly, complex, or cold-chain-dependent detection systems—no antibodies required.

Drop-in alternatives to conventional assays—faster, cheaper, antibody-free.

  • MAADWBTM™ – Molecular replacement for Western blotting
  • MAADELASA™ – Substrate-driven alternative to ELISA
  • MAADFlow™ – Flow cytometry substitute using MAAD-labeled tags
  • MAAD PK™ – LC-MS/MS alternative via anchored metabolite sensors
  • MAADCytokine™ – Printed cytokine panel alternative using peptide-peptide binding arrays

For low-cost, non-lab-based detection—designed for global health & remote care.

  • MAAD Melanoma™ – Topical spray to detect tumor biomarkers at the surface
  • MAADUrine™ – Subcutaneous aptamer/metabolite sensor cleared through urine
  • MAADPatch™ / Dermasense™ – Skin-applied sensors for inflammation, stress, or infection
  • MAAD Biowipe™ – Surface wipe test for pathogen, toxin, or residue detection

Ultra-low-cost, shelf-stable, and scalable tools—no special equipment needed.

  • XeroPrint™ – Paper-based diagnostic kits using MAAD-linked peptide tags
  • MAADTag™ – Modular molecular tagging system for multiplexed analyte detection

Have niche expertise? A problem to solve? A tool that needs better chemistry?

MAAD is actively seeking collaborators, co-developers, and diagnostic startups ready to transform the way we detect, tag, and analyze. Our modular chemistry can integrate into your system—whether you’re working on paper-based kits, wearable sensors, or lab-free diagnostics.

What We Offer:

  • Plug-in chemistry, ready for your platform
  • Co-owned IP opportunities
  • Startup-friendly licensing & royalties
  • Support for grant writing, pilot design, and patent strategy